Nuzenio

Stock Titan Post

Stock Titan Post news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Envoy Medical (NASDAQ: COCH) burns cash on Acclaim implant trial after $28M raise - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 12:32:22 GMTJerash Holdings (NASDAQ: JRSH) posts record Q1 FY2027 revenue and profit surge - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 12:11:04 GMTCogent Biosciences (COGT) widens Q2 loss but nears FDA decisions on bezuclastinib - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 12:06:57 GMTNayax (NASDAQ: NYAX) grows Q2 revenue 28% while cutting 2026 free cash flow outlook - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 11:31:49 GMTCamtek Ltd. (NASDAQ: CAMT) posts record Q2 2026 sales and projects strong H2 growth - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 11:16:45 GMTPassage Bio (PASG) outlines Q2 2026 loss, cash strain and Remix merger terms - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 11:16:45 GMTWestern Midstream Plans Five Investor Conference Appearances by Sept. 30 - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 11:02:20 GMTEmbraer (EMBJ) lifts 2026 margin outlook after record Q2 2026 results - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 10:20:11 GMT

Timeline

Mon, 10 Aug 2026 12:32:22 GMTEnvoy Medical (NASDAQ: COCH) burns cash on Acclaim implant trial after $28M raise - stocktitan.net
Mon, 10 Aug 2026 12:11:04 GMTJerash Holdings (NASDAQ: JRSH) posts record Q1 FY2027 revenue and profit surge - stocktitan.net
Mon, 10 Aug 2026 12:06:57 GMTCogent Biosciences (COGT) widens Q2 loss but nears FDA decisions on bezuclastinib - stocktitan.net
Mon, 10 Aug 2026 11:31:49 GMTNayax (NASDAQ: NYAX) grows Q2 revenue 28% while cutting 2026 free cash flow outlook - stocktitan.net
Mon, 10 Aug 2026 11:16:45 GMTCamtek Ltd. (NASDAQ: CAMT) posts record Q2 2026 sales and projects strong H2 growth - stocktitan.net
Mon, 10 Aug 2026 11:16:45 GMTPassage Bio (PASG) outlines Q2 2026 loss, cash strain and Remix merger terms - stocktitan.net

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Post.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.